Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC)
Article in Journal for ImmunoTherapy of Cancer (June 2024)
The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.
The tumor microenvironment’s in pancreatic cancer: Effects on immunotherapy success and novel strategies to overcome the hostile environment
Article in Pathology - Research and Practice (May 2024)
PD‐1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study
Article in Cancer Medicine (April 2024)